全文获取类型
收费全文 | 815篇 |
免费 | 4篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 23篇 |
妇产科学 | 2篇 |
基础医学 | 202篇 |
口腔科学 | 14篇 |
临床医学 | 112篇 |
内科学 | 95篇 |
皮肤病学 | 30篇 |
神经病学 | 10篇 |
特种医学 | 7篇 |
外科学 | 55篇 |
综合类 | 6篇 |
预防医学 | 82篇 |
眼科学 | 8篇 |
药学 | 161篇 |
肿瘤学 | 11篇 |
出版年
2021年 | 11篇 |
2017年 | 8篇 |
2014年 | 8篇 |
2012年 | 16篇 |
2011年 | 15篇 |
2010年 | 19篇 |
2009年 | 11篇 |
2008年 | 13篇 |
2007年 | 28篇 |
2006年 | 24篇 |
2005年 | 9篇 |
2004年 | 13篇 |
2003年 | 9篇 |
2002年 | 18篇 |
2001年 | 25篇 |
2000年 | 14篇 |
1999年 | 9篇 |
1998年 | 15篇 |
1997年 | 8篇 |
1996年 | 9篇 |
1995年 | 18篇 |
1994年 | 7篇 |
1993年 | 7篇 |
1992年 | 7篇 |
1991年 | 26篇 |
1990年 | 26篇 |
1989年 | 27篇 |
1988年 | 25篇 |
1987年 | 25篇 |
1986年 | 25篇 |
1985年 | 19篇 |
1984年 | 17篇 |
1983年 | 18篇 |
1982年 | 10篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 22篇 |
1978年 | 19篇 |
1977年 | 16篇 |
1976年 | 12篇 |
1975年 | 22篇 |
1974年 | 19篇 |
1973年 | 17篇 |
1972年 | 18篇 |
1971年 | 20篇 |
1970年 | 15篇 |
1969年 | 16篇 |
1968年 | 10篇 |
1967年 | 14篇 |
1966年 | 14篇 |
排序方式: 共有832条查询结果,搜索用时 15 毫秒
1.
V Aerra M Kuduvalli AN Moloto AK Srinivasan AD Grayson BM Fabri AY Oo 《Journal of cardiothoracic surgery》2006,1(1):6-5
Background
Atrial fibrillation can occur in up to 40% of patients undergoing coronary surgery. 相似文献2.
3.
4.
5.
T. V. Golovko N. I. Mikerova L. M. Alekseeva G. A. Bogdanova V. A. Parshin V. V. Asnina R. B. Parimbetova V. G. Granik 《Pharmaceutical Chemistry Journal》1994,28(4):236-242
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 28, No. 4, pp. 22–26, April, 1994. 相似文献
6.
BACKGROUND: There are obvious advantages to increasing donor retention. However, for reasons of blood safety, certain donors may, in fact, be more desirable to retain than others. “Safe” donors are defined as those who provided a blood donation that was negative on all laboratory screening tests and who subsequently reported no behavioral risks in response to an anonymous survey. This study identifies the most important factors affecting the intention of “safe” donors to provide another donation. STUDY DESIGN AND METHODS: An anonymous survey asking about donation history, sexual history, injecting drug use, and recent donation experience was mailed to 50,162 randomly selected allogeneic donors (including directed donors) who gave blood from April through July or from October through December 1993 at one of the five United States blood centers participating in the Retrovirus Epidemiology Donor Study. Before mailing, questionnaires were coded to designate donors with nonreactive laboratory screening tests at their most recent donation. RESULTS: A total of 34,726 donors (69%) responded, with substantially higher response among repeat donors. According to reported intentions only, the vast majority of “safe” donors indicated a high likelihood of donating again within the next 12 months. Only 3.4 percent reported a low likelihood of donating again. A comparison of those likely to return and those unlikely to return reveals significant differences in demographics and in ratings of the donation experience. A higher proportion of those unlikely to return were first-time donors, minority-group donors, and donors with less education. The highest projected loss among “safe” donors was seen for those who gave a fair to poor assessment of their treatment by blood center staff or of their physical well-being during or after donating. CONCLUSION: These data suggest that efforts to improve donors' perceptions of their donation experience, as well as attention to the physical effects of blood donation, may aid in the retention of both repeat and first-time donors. 相似文献
7.
8.
V. M. Lyubchanskaya L. M. Alekseeva I. S. Nikolaeva M. G. Il'ina A. N. Fomina V. G. Granik 《Pharmaceutical Chemistry Journal》1991,25(4):260-263
Translated from Khimiko-farmatsevitcheskii Zhurnal, Vol. 25, No. 4, pp. 35–37, April, 1991. 相似文献
9.
S. A. Zaitsev O. A. Onuchina L. M. Alekseeva A. P. Arzamastsev M. A. Kalinkina V. G. Granik 《Pharmaceutical Chemistry Journal》2005,39(12):636-640
Two benzofuran derivatives — analogs of 5-lipoxygenase antagonist zileuton — have been synthesized and tested. It is established
that both compounds possess antiinflammatory activity.
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 39, No. 12, pp. 17–20, December, 2005. 相似文献
10.
A. A. Firsov I. B. Kadenatsi E. V. Gagaeva V. S. Dombrovskii S. E. Kuleshov M. E. Alekseeva 《Pharmaceutical Chemistry Journal》1995,29(4):241-244
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 29, No. 4, pp. 18–21, April, 1995. 相似文献